|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 11 (June 1), 2000:
pp. 3620-3627
Cotransplantation of human stromal cell progenitors into preimmune
fetal sheep results in early appearance of human donor cells in
circulation and boosts cell levels in bone marrow at later time points
after transplantation
Graça Almeida-Porada,
Christopher D. Porada,
Nam Tran, and
Esmail D. Zanjani
Department of Veterans Affairs Medical Center, University of Nevada
Reno, Reno, NV.
Both in utero and postnatal hematopoietic stem cell (HSC)
transplantation would benefit from the development of approaches that
produce increased levels of engraftment or a reduction in the period of
time required for reconstitution. We used the in utero model of
human-sheep HSC transplantation to investigate ways of improving
engraftment and differentiation of donor cells after transplantation.
We hypothesized that providing a more suitable microenvironment in the
form of human stromal cell progenitors simultaneously with the
transplanted human HSC would result in higher rates of engraftment or
differentiation of the human cells in this xenogeneic model. The
results presented here demonstrate that the cotransplantation of both
autologous and allogeneic human bone marrow-derived stromal cell
progenitors resulted in an enhancement of long-term engraftment of
human cells in the bone marrow of the chimeric animals and in earlier
and higher levels of donor cells in circulation both during gestation
and after birth. By using marked stromal cells, we have also
demonstrated that injected stromal cells alone engraft and remain
functional within the sheep hematopoietic microenvironment. Application
of this method to clinical HSC transplantation could potentially lead
to increased levels of long-term engraftment, a reduction in the time
for hematopoietic reconstitution, and a means of delivery of foreign
genes to the hematopoietic system.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
X.-Y. Wang, Y. Lan, W.-Y. He, L. Zhang, H.-Y. Yao, C.-M. Hou, Y. Tong, Y.-L. Liu, G. Yang, X.-D. Liu, et al.
Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos
Blood,
February 15, 2008;
111(4):
2436 - 2443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tomiyama, N. Murase, D. B. Stolz, H. Toyokawa, D. R. O'Donnell, D. M. Smith, J. R. Dudas, J. P. Rubin, and K. G. Marra
Characterization of Transplanted Green Fluorescent Protein+ Bone Marrow Cells into Adipose Tissue
Stem Cells,
February 1, 2008;
26(2):
330 - 338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech
The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities
Stem Cells,
July 1, 2007;
25(7):
1737 - 1745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. FIBBE, A. J. NAUTA, and H. ROELOFS
Modulation of Immune Responses by Mesenchymal Stem Cells
Ann. N.Y. Acad. Sci.,
June 1, 2007;
1106(1):
272 - 278.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Bocelli-Tyndall, L. Bracci, G. Spagnoli, A. Braccini, M. Bouchenaki, R. Ceredig, V. Pistoia, I. Martin, and A. Tyndall
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
Rheumatology,
March 1, 2007;
46(3):
403 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Chan, M. Choi, S. Wnendt, M. Kraus, E. Teng, H. F. Leong, and S. Merchav
Enhanced In Vivo Homing of Uncultured and Selectively Amplified Cord Blood CD34+ Cells by Cotransplantation with Cord Blood-Derived Unrestricted Somatic Stem Cells
Stem Cells,
February 1, 2007;
25(2):
529 - 536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. E. Meyerrose, D. A. De Ugarte, A. A. Hofling, P. E. Herrbrich, T. D. Cordonnier, L. D. Shultz, J. C. Eagon, L. Wirthlin, M. S. Sands, M. A. Hedrick, et al.
In Vivo Distribution of Human Adipose-Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models
Stem Cells,
January 1, 2007;
25(1):
220 - 227.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. van Laar and A. Tyndall
Adult stem cells in the treatment of autoimmune diseases
Rheumatology,
October 1, 2006;
45(10):
1187 - 1193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Nauta, G. Westerhuis, A. B. Kruisselbrink, E. G. A. Lurvink, R. Willemze, and W. E. Fibbe
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Blood,
September 15, 2006;
108(6):
2114 - 2120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Chen, H. Xu, C. Wan, M. McCaigue, and G. Li
Bioreactor Expansion of Human Adult Bone Marrow-Derived Mesenchymal Stem Cells
Stem Cells,
September 1, 2006;
24(9):
2052 - 2059.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zeng, M.-j. Chen, D. A. Baldwin, Z.-j. Gong, J.-b. Yan, H. Qian, J. Wang, X. Jiang, Z.-r. Ren, D. Sun, et al.
Multiorgan engraftment and differentiation of human cord blood CD34+Lin- cells in goats assessed by gene expression profiling
PNAS,
May 16, 2006;
103(20):
7801 - 7806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Mendes, C. Robin, and E. Dzierzak
Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny
Development,
March 1, 2005;
132(5):
1127 - 1136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Shields, L. Gaur, P. Delio, J. Potter, A. Sieverkropp, and R. G. Andrews
Fetal Immune Suppression as Adjunctive Therapy for In Utero Hematopoietic Stem Cell Transplantation in Nonhuman Primates
Stem Cells,
September 1, 2004;
22(5):
759 - 769.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bensidhoum, A. Chapel, S. Francois, C. Demarquay, C. Mazurier, L. Fouillard, S. Bouchet, J. M. Bertho, P. Gourmelon, J. Aigueperse, et al.
Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment
Blood,
May 1, 2004;
103(9):
3313 - 3319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Cancedda, G. Bianchi, A. Derubeis, and R. Quarto
Cell Therapy for Bone Disease: A Review of Current Status
Stem Cells,
September 1, 2003;
21(5):
610 - 619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. in `t Anker, S. A. Scherjon, C. Kleijburg-van der Keur, W. A. Noort, F. H. J. Claas, R. Willemze, W. E. Fibbe, and H. H. H. Kanhai
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation
Blood,
August 15, 2003;
102(4):
1548 - 1549.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. FIBBE and W. A. NOORT
Mesenchymal Stem Cells and Hematopoietic Stem Cell Transplantation
Ann. N.Y. Acad. Sci.,
May 1, 2003;
996(1):
235 - 244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Ho and M. Punzel
Hematopoietic stem cells: can old cells learn new tricks?
J. Leukoc. Biol.,
May 1, 2003;
73(5):
547 - 555.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Shields, L. K. Gaur, M. Gough, J. Potter, A. Sieverkropp, and R. G. Andrews
In Utero Hematopoietic Stem Cell Transplantation in Nonhuman Primates: The Role of T Cells
Stem Cells,
May 1, 2003;
21(3):
304 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P. D. Longoni, P. Matteucci, S. Grisanti, and A. M. Gianni
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
Blood,
May 15, 2002;
99(10):
3838 - 3843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Taylor, R. T. McElmurry, C. J. Lees, D. E. Harrison, and B. R. Blazar
Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients
Blood,
March 1, 2002;
99(5):
1870 - 1872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Campagnoli, I. A. G. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
Blood,
October 15, 2001;
98(8):
2396 - 2402.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Minguell, A. Erices, and P. Conget
Mesenchymal Stem Cells
Experimental Biology and Medicine,
June 1, 2001;
226(6):
507 - 520.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Cilloni, C. Carlo-Stella, F. Falzetti, G. Sammarelli, E. Regazzi, S. Colla, V. Rizzoli, F. Aversa, M. F. Martelli, and A. Tabilio
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation
Blood,
November 15, 2000;
96(10):
3637 - 3643.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
